The impact of prevention-effective PrEP use on HIV incidence: a mathematical modelling study.

Journal Information

Full Title: J Int AIDS Soc

Abbreviation: J Int AIDS Soc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Acquired Immunodeficiency Syndrome

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Evidence found in paper:

"the code used to run emod for this analysis is available on github ( https://github com/dallenroberts/prep-risk )."

Evidence found in paper:

"COMPETING INTERESTS RVB reports grants from the Bill & Melinda Gates Foundation (BMGF) and the National Institutes of Health (NIH); and Regeneron Pharmaceuticals for conference abstract and manuscript writing support, outside the submitted work. JEH reports grants from the National Institutes of Health (NIH); and consultative fees from Merck outside the submitted work. No other authors report competing interests."

Evidence found in paper:

"FUNDING DAR received support from the US National Institute of Health (NIH) [F30MH122300]. JEH received support from the US National Institute of Health [K24MH114732]. This work is based on research funded in part by the Bill & Melinda Gates Foundation, including models and data analysis performed by the Institute for Disease Modeling at the Bill & Melinda Gates Foundation."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025